Publication: 2836

Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance)
      QxMD      Google Scholar   
Citation:
Oncologist vol 23 (8) 887-e94
Year:
2018
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
7
Parents:
545  
Children:
None
Program:
OGC
Primary Committee:
Experimental
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U10CA180790  
Corr. Author:
 
Authors:
                       
Networks:
IA094, LAPS-MN026   
Study
NCCTG-N0377
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: